ELUT
Elutia Inc - Ordinary Shares - Class A

670
Loading...
Loading...
News
all
press releases
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround
ELUTIA INC (ELUT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·30d ago
News Placeholder
More News
News Placeholder
All You Need to Know About ELUTIA INC (ELUT) Rating Upgrade to Buy
ELUTIA INC (ELUT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
News Placeholder
Contrasting Elutia (NASDAQ:ELUT) & CG Oncology (NASDAQ:CGON)
Elutia (NASDAQ:ELUT Get Free Report) and CG Oncology (NASDAQ:CGON Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses...
Zolmax·2y ago
News Placeholder
Head to Head Survey: Elutia (NASDAQ:ELUT) vs. Pluri (NASDAQ:PLUR)
Elutia (NASDAQ:ELUT Get Free Report) and Pluri (NASDAQ:PLUR Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...
Zolmax·2y ago
News Placeholder
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM Clearance Decision in First Half of 2024
SILVER SPRING, Md., March 07, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia or the Company ) today provided a business update and reported financial results for the fourth quarter...
Globe Newswire·2y ago
News Placeholder
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
SILVER SPRING, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a company pioneering drug-eluting biomatrix products, today announced that it will release its fourth...
Globe Newswire·2y ago
News Placeholder
Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues
You may think that with a price-to-sales (or "P/S") ratio of 1.5x Elutia Inc. ( NASDAQ:ELUT ) is definitely a stock...
Simply Wall St·2y ago
News Placeholder
Elutia management to meet with Lake Street
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants...
Proactive Investors - UK·2y ago
News Placeholder
Elutia Regains Compliance with Nasdaq Listing Requirements
SILVER SPRING, Md., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) today announced that it has regained compliance with Nasdaq's market value of listed securities requirement and...
Globe Newswire·2y ago

Latest ELUT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.